Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |